glp 1 for heart health GLP-1 Agonists and Rate Heart and health behavior responses
Description
Not medical advice, diagnosis, treatment, prescribing guidance, medication sourcing, emergency support, or dosing guidance
Ryan AT, Feinle-Bisset C, Kallas A, Wishart JM, Clifton PM, Horowitz M et al
As a result, Novo Nordisk and Eli Lilly were able to maximize the rise in sales and lack of insurance coverage under the guise of inflation
others with GLP1R variants may show reduced baseline receptor sensitivity, potentially informing GLP-1 dosing decisions
